05:06am Saturday 14 December 2019

GUMC Invites Men and Women with Memory Problems to Take Part in Study

Men and women between the ages of 55 and 90 with very early complaints of memory problems might qualify to participate in the trial. The study uses imaging techniques specifically developed to advance research into changes taking place in the structure and function of the brain, as well as biomarker measures found in blood and cerebrospinal fluid. Participants will be asked to undergo three test procedures (MRI and PET scans, lumbar puncture). The study does not provide treatment and does not directly benefit its participant, but the information gathered will help future generations with cognitive decline and Alzheimer’s.

“We cannot end this terrible disease unless we know more about it,” said Brigid Reynolds, A.N.P., principal investigator of the study at GUMC. “This is where volunteers, their friends and their families can make the difference in our success.”

According to the National Institute of Aging, more than 5.3 million people in the U.S. are suffering from Alzheimer’s, and every 70 seconds, another person develops this disease. In Washington, DC, approximately more than 9,000 people aged 65 and older are currently living with Alzheimer’s making finding a cure a pressing need in our community.

The Alzheimer’s Disease Neuroimaging Initiative Grand Opportunity study, called ADNI-GO, is funded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), and the NIH Office of the Director. In addition to the Georgetown University Memory Disorders Program, 49 other sites in the United States are participating in the study.

“ADNI-GO is part of an ongoing effort to establish imaging and fluid biomarker measures of Alzheimer’s disease from the onset of mild symptoms to the advanced stages of the disease process,” said NIA Director Richard J. Hodes, M.D. “By advancing the understanding of the full spectrum of the disease, we’ll be better able to identify who is at risk, track progression of the disorder, and devise measurements to test the effectiveness of potential prevention or treatment strategies.”

To volunteer or learn more about the study, contact Kelly Behan in the GUMC Memory Disorders Program by calling (202) 687-0413 or by emailing her at keb53@georgetown.edu. Volunteers must speak English and have a person willing to assist them during at least five clinic visits and with telephone contacts from researchers.

Click here to learn more about ADNI GO or visit the Memory Disorders Program

About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university’s sponsored research funding.



Karen Mallet (media only)

Share on:

MORE FROM Drugs Approvals and Trials

Health news